title: [Validation of an instrument for screening cases of type 2 diabetes and monitoring at-risk individuals in Mexico].
abstract: OBJECTIVE
  To validate a method for screening cases of type 2 diabetes and monitoring at-risk people in a community in northern Mexico.
  
  
  METHODS
  The screening instrument for type 2 diabetes (ITD, for its Spanish acronym) was developed using a multiple logistic regression analysis that made it possible to determine the association between a new diagnosis of diabetes (a dependent variable) and 11 known risk factors. Internal validations were performed (through v-fold cross-validation), together with external validations (through the monitoring of a cohort of healthy individuals). In order to estimate the relative risk (RR) of developing type 2 diabetes, the total ITD score is calculated on the basis of an individual's risk factors and compared against a curve that shows the probability of that individual developing the disease.
  
  
  RESULTS
  Of the 525 people in the cohort, 438 (83.4%) were followed for an average of 7 years (4.5 to 10 years), for a total of 2 696 person-years; 62 (14.2%) people developed diabetes during the time they were followed. Individuals scoring 55 points based on their risk factors demonstrated a significantly higher risk of developing diabetes in 7 years (RR = 6.1; IC95%: 1.7 to 11.1); the risk was even higher for those with a score of 75 points (RR = 9.4; IC95%: 2.1 to 11.5).
  
  
  CONCLUSIONS
  The ITD is easy to use and a valid screening alternative for type 2 diabetes. Its use will allow more individuals to benefit from disease prevention methods and early diagnosis without substantially increasing costs and with minimal use of laboratory resources.
authors.affiliation: Instituto Mexicano del Seguro Social, Durango, México 34000.
authors.forename: Fernando
authors.initials: F
authors.lastname: Guerrero-Romero
authors.forename: Martha
authors.initials: M
authors.lastname: Rodríguez-Morán
mesh_terms: D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D008800:Mexico; D011159:Population Surveillance; D012307:Risk Factors